Trial intelligence / Profile preview

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China

NCT01340950Phase 4Completed

Sponsor
University of California, San Diego
Start
Jul 2010
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zidovudine, lamivudine, nevirapine in HIV-associated neurocognitive disorder (HAND), sponsored by University of California, San Diego. Started Jul 2010; status: completed.

02

Drugs

zidovudinelamivudinenevirapine
03

Conditions

HIV-associated neurocognitive disorder (HAND)

Beyond the preview

Go deeper on NCT01340950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01340950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call